Review



anti human mouse trem2  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    R&D Systems anti human mouse trem2
    Anti Human Mouse Trem2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/trem2+antibodies/bio_rxiv__64898__2026__04__02__716182-287-25-29?v=R%26D+Systems
    Average 93 stars, based on 6 article reviews
    anti human mouse trem2 - by Bioz Stars, 2026-07
    93/100 stars

    Images



    Similar Products

    human/mouse trem2 apc-conjugated antibody  (Bio-Techne corporation)
    99
    Bio-Techne corporation human/mouse trem2 apc-conjugated antibody
    Human/Mouse Trem2 Apc Conjugated Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/trem2+antibodies/bio-techne+corporation___fab17291a?v=Bio-Techne+corporation
    Average 99 stars, based on 1 article reviews
    human/mouse trem2 apc-conjugated antibody - by Bioz Stars, 2026-07
    99/100 stars
    		  Buy from Supplier
    bioss bs 2723r  (Bioss)
    94
    Bioss bioss bs 2723r
    Bioss Bs 2723r, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/trem2+antibodies/pmc13106476-97-31-31?v=Bioss
    Average 94 stars, based on 1 article reviews
    bioss bs 2723r - by Bioz Stars, 2026-07
    94/100 stars
    		  Buy from Supplier
    trem2 antibody agonist  (Novartis)
    86
    Novartis trem2 antibody agonist
    Trem2 Antibody Agonist, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/trem2+antibodies/pmc13140253-116-7-19?v=Novartis
    Average 86 stars, based on 1 article reviews
    trem2 antibody agonist - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    rabbit anti nlr family pyrin domain  (Bioss)
    94
    Bioss rabbit anti nlr family pyrin domain
    Rabbit Anti Nlr Family Pyrin Domain, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/trem2+antibodies/pmc13106476-97-33-31?v=Bioss
    Average 94 stars, based on 1 article reviews
    rabbit anti nlr family pyrin domain - by Bioz Stars, 2026-07
    94/100 stars
    		  Buy from Supplier
    anti human mouse trem2  (R&D Systems)
    93
    R&D Systems anti human mouse trem2
    Anti Human Mouse Trem2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/trem2+antibodies/bio_rxiv__64898__2026__04__02__716182-287-25-29?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    anti human mouse trem2 - by Bioz Stars, 2026-07
    93/100 stars
    		  Buy from Supplier
    rabbit polyclonal anti trem2 antibody  (MedChemExpress)
    93
    MedChemExpress rabbit polyclonal anti trem2 antibody
    Enrichment analysis and immune-cell infiltration based on risk groups. (A) GSEA analysis showing top 5 pathways between low- and high-risk groups. (B) Heatmap of differences in pathways between low- and high-risk groups. (C) Stacked bar chart showing infiltration proportions of immune cells using ssGSEA. (D) Correlation analysis of FNDC1, S100A8, and <t>TREM2</t> with differential immune infiltrating cells. (E) Box plot of differences in 7 types of immune cells within the low- and high-risk groups. (F) Correlation analysis between S100A8 and neutrophils. (G) The differences in the scores of dysfunction, exclusion, MSI, and TIDE between low- and high-risk groups. (H) The differences in the expression of immune checkpoint between low- and high-risk groups. Ns, not significant. * indicate p<0.05, ** indicate p<0.01, *** indicate p<0.001, **** indicate p<0.0001.
    Rabbit Polyclonal Anti Trem2 Antibody, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/trem2+antibodies/pmc13082966-119-20-30?v=MedChemExpress
    Average 93 stars, based on 1 article reviews
    rabbit polyclonal anti trem2 antibody - by Bioz Stars, 2026-07
    93/100 stars
    		  Buy from Supplier
    trem2  (Santa Cruz Biotechnology)
    93
    Santa Cruz Biotechnology trem2
    Enrichment analysis and immune-cell infiltration based on risk groups. (A) GSEA analysis showing top 5 pathways between low- and high-risk groups. (B) Heatmap of differences in pathways between low- and high-risk groups. (C) Stacked bar chart showing infiltration proportions of immune cells using ssGSEA. (D) Correlation analysis of FNDC1, S100A8, and <t>TREM2</t> with differential immune infiltrating cells. (E) Box plot of differences in 7 types of immune cells within the low- and high-risk groups. (F) Correlation analysis between S100A8 and neutrophils. (G) The differences in the scores of dysfunction, exclusion, MSI, and TIDE between low- and high-risk groups. (H) The differences in the expression of immune checkpoint between low- and high-risk groups. Ns, not significant. * indicate p<0.05, ** indicate p<0.01, *** indicate p<0.001, **** indicate p<0.0001.
    Trem2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/trem2+antibodies/pm41876457-98-11-23?v=Santa+Cruz+Biotechnology
    Average 93 stars, based on 1 article reviews
    trem2 - by Bioz Stars, 2026-07
    93/100 stars
    		  Buy from Supplier
    trem2  (R&D Systems)
    95
    R&D Systems trem2
    Enrichment analysis and immune-cell infiltration based on risk groups. (A) GSEA analysis showing top 5 pathways between low- and high-risk groups. (B) Heatmap of differences in pathways between low- and high-risk groups. (C) Stacked bar chart showing infiltration proportions of immune cells using ssGSEA. (D) Correlation analysis of FNDC1, S100A8, and <t>TREM2</t> with differential immune infiltrating cells. (E) Box plot of differences in 7 types of immune cells within the low- and high-risk groups. (F) Correlation analysis between S100A8 and neutrophils. (G) The differences in the scores of dysfunction, exclusion, MSI, and TIDE between low- and high-risk groups. (H) The differences in the expression of immune checkpoint between low- and high-risk groups. Ns, not significant. * indicate p<0.05, ** indicate p<0.01, *** indicate p<0.001, **** indicate p<0.0001.
    Trem2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/trem2+antibodies/pm41896221-95-45-46?v=R%26D+Systems
    Average 95 stars, based on 1 article reviews
    trem2 - by Bioz Stars, 2026-07
    95/100 stars
    		  Buy from Supplier
    china hy p80920 rabb  (MedChemExpress)
    93
    MedChemExpress china hy p80920 rabb
    Enrichment analysis and immune-cell infiltration based on risk groups. (A) GSEA analysis showing top 5 pathways between low- and high-risk groups. (B) Heatmap of differences in pathways between low- and high-risk groups. (C) Stacked bar chart showing infiltration proportions of immune cells using ssGSEA. (D) Correlation analysis of FNDC1, S100A8, and <t>TREM2</t> with differential immune infiltrating cells. (E) Box plot of differences in 7 types of immune cells within the low- and high-risk groups. (F) Correlation analysis between S100A8 and neutrophils. (G) The differences in the scores of dysfunction, exclusion, MSI, and TIDE between low- and high-risk groups. (H) The differences in the expression of immune checkpoint between low- and high-risk groups. Ns, not significant. * indicate p<0.05, ** indicate p<0.01, *** indicate p<0.001, **** indicate p<0.0001.
    China Hy P80920 Rabb, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/trem2+antibodies/pm41888656-156-84-83?v=MedChemExpress
    Average 93 stars, based on 1 article reviews
    china hy p80920 rabb - by Bioz Stars, 2026-07
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    Enrichment analysis and immune-cell infiltration based on risk groups. (A) GSEA analysis showing top 5 pathways between low- and high-risk groups. (B) Heatmap of differences in pathways between low- and high-risk groups. (C) Stacked bar chart showing infiltration proportions of immune cells using ssGSEA. (D) Correlation analysis of FNDC1, S100A8, and TREM2 with differential immune infiltrating cells. (E) Box plot of differences in 7 types of immune cells within the low- and high-risk groups. (F) Correlation analysis between S100A8 and neutrophils. (G) The differences in the scores of dysfunction, exclusion, MSI, and TIDE between low- and high-risk groups. (H) The differences in the expression of immune checkpoint between low- and high-risk groups. Ns, not significant. * indicate p<0.05, ** indicate p<0.01, *** indicate p<0.001, **** indicate p<0.0001.

    Journal: Frontiers in Oncology

    Article Title: A novel prognostic signature based on mitochondrial permeability transition-driven necrosis genes for biochemical recurrence prediction in prostate cancer

    doi: 10.3389/fonc.2026.1775602

    Figure Lengend Snippet: Enrichment analysis and immune-cell infiltration based on risk groups. (A) GSEA analysis showing top 5 pathways between low- and high-risk groups. (B) Heatmap of differences in pathways between low- and high-risk groups. (C) Stacked bar chart showing infiltration proportions of immune cells using ssGSEA. (D) Correlation analysis of FNDC1, S100A8, and TREM2 with differential immune infiltrating cells. (E) Box plot of differences in 7 types of immune cells within the low- and high-risk groups. (F) Correlation analysis between S100A8 and neutrophils. (G) The differences in the scores of dysfunction, exclusion, MSI, and TIDE between low- and high-risk groups. (H) The differences in the expression of immune checkpoint between low- and high-risk groups. Ns, not significant. * indicate p<0.05, ** indicate p<0.01, *** indicate p<0.001, **** indicate p<0.0001.

    Article Snippet: The following were the antibody concentrations for western blotting: rabbit polyclonal anti-FNDC1 antibody (1:1000, catalog no. bs-8460R; Bioss, Beijing, China), rabbit polyclonal anti-TREM2 antibody (1:1000, catalog no. HY- P80920 ; MedChemExpress, Monmouth Junction, NJ, USA), and rabbit polyclonal anti-S100A8 antibody (1:1000, catalog no. AF7929; Beyotime, Shanghai, China), and mouse monoclonal anti-GAPDH (1:2000, 60004-1-Ig, Proteintech, China).

    Techniques: Expressing

    Validation of FNDC1, S100A8, and TREM2 expression. (A) The mRNA expression levels of FNDC1, S100A8, and TREM2 in TCGA-PRAD cohort. (B) The mRNA expression levels of FNDC1, S100A8 and TREM2 were confirmed by q-PCR between paratumor(PT) and prostate cancer tissue. (C, D) The protein expression levels of FNDC1, S100A8 and TREM2 were confirmed by western blot between paratumor(PT) and prostate cancer tissue(T). (E) Immunohistochemistry micrographs revealing FNDC1, S100A8 and TREM2 expression between paratumor(PT) and prostate cancer tissue(T). **P< 0.01; ***P< 0.001.

    Journal: Frontiers in Oncology

    Article Title: A novel prognostic signature based on mitochondrial permeability transition-driven necrosis genes for biochemical recurrence prediction in prostate cancer

    doi: 10.3389/fonc.2026.1775602

    Figure Lengend Snippet: Validation of FNDC1, S100A8, and TREM2 expression. (A) The mRNA expression levels of FNDC1, S100A8, and TREM2 in TCGA-PRAD cohort. (B) The mRNA expression levels of FNDC1, S100A8 and TREM2 were confirmed by q-PCR between paratumor(PT) and prostate cancer tissue. (C, D) The protein expression levels of FNDC1, S100A8 and TREM2 were confirmed by western blot between paratumor(PT) and prostate cancer tissue(T). (E) Immunohistochemistry micrographs revealing FNDC1, S100A8 and TREM2 expression between paratumor(PT) and prostate cancer tissue(T). **P< 0.01; ***P< 0.001.

    Article Snippet: The following were the antibody concentrations for western blotting: rabbit polyclonal anti-FNDC1 antibody (1:1000, catalog no. bs-8460R; Bioss, Beijing, China), rabbit polyclonal anti-TREM2 antibody (1:1000, catalog no. HY- P80920 ; MedChemExpress, Monmouth Junction, NJ, USA), and rabbit polyclonal anti-S100A8 antibody (1:1000, catalog no. AF7929; Beyotime, Shanghai, China), and mouse monoclonal anti-GAPDH (1:2000, 60004-1-Ig, Proteintech, China).

    Techniques: Biomarker Discovery, Expressing, Western Blot, Immunohistochemistry